Methylphenidate for Treating Children With ADHD and Tourette Syndrome

• Status: Completed
• Trial end date: 2007-01-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate the safety and effectiveness of methylphenidate in treating attention deficit hyperactivity disorder in children with both attention deficit hyperactivity disorder and Tourette syndrome.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Stony Brook University
• Collaborator: National Institute of Mental Health (NIMH)
• Treatments: Methylphenidate

Criteria

Inclusion Criteria:

• Diagnosis of ADHD or ADHD plus Tourette syndrome

Exclusion Criteria:

• Determined to be dangerous to self or others

• Scores less than 70 on an IQ test

• Any seizure disorder, major organic brain dysfunction, major medical illness, major mood disorder, psychosis, pervasive developmental disorder, or peripheral sensory loss

• Any condition that may make use of methylphenidate unsafe